Long-term continuous use of benzodiazepines by older adults in Quebec: Prevalence, incidence and risk factors

Journal of the American Geriatrics Society

Volumn 48, Issue 7, 2000, Pages 811-816

  Egan, Mary ^a   Moride, Yola ^b   Wolfson, Christina ^b   Monette, Johanne ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE

Author keywords

Aged; Benzodiazepines; Canadian Study of Health and Aging; Follow up studies

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CHLORDIAZEPOXIDE; DIAZEPAM; FLURAZEPAM; LORAZEPAM; NITRAZEPAM; TEMAZEPAM; TRIAZOLAM;

AGED; AGING; ANXIETY NEUROSIS; ARTICLE; CANADA; DRUG UTILIZATION; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHYSICIAN ATTITUDE; POPULATION RESEARCH; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR;

EID: 0033917791     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2000.tb04758.x     Document Type: Article

References (39)

1. Fancourt G, Castleden M. The use of benzodiazepines with particular reference to the elderly. Br J Hosp Med 1986;35:321-326.
2. Juergens SM. Problems with benzodiazepines in elderly patients. Mayo Clin Proc 1993;68:818-820.
3. Maletta G, Mattox KM, Dysken M. Guidelines for prescribing psychoactive drugs in the elderly: Part 1. Geriatrics 1991;46(Sept):40-47.
4. Curran HV. Tranquilising memories: A review of the effects of benzodiazepines on human memory. Biol Psychiatry 1986;23:179-213.
5. Ghoneim MM, Mewaldr SP. Benzodiazepines and human memory. Anesthesiology 1990;72:926-938.
6. Rummans TA, Davis LJ, Morse RM, Ivnik RJ. Learning and memory impairment in older, detoxified, benzodiazepine-dependent patients. Mayo Clin Proc 1993;68:731-737.
7. Reifler BV. Pre-dementia. J Am Geriatr Soc 1997;45:776-777.
8. Kales A, Kales JD. Sleep laboratory studies of hypnotic drugs: Efficacy and withdrawal effects. J Clin Psychopharmacol 1983;3:140-150.
9. Kales A, Bixler EO, Vela-Bueno A et al. Alprazolam: Effects on sleep and withdrawal phenomena. J Clin Pharmacol 1987;27:508-515.
10. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: A systematic review and meta-analysis. J Am Geriatr Soc 1999;47:30-39.
11. Herings RMC, Stricker BH, de Boer A et al.. Benzodiazepines and the risk of falling leading to femur fractures. Arch Intern Med 1995;155:1801-1807.
12. Ray WA, Griffin MR, Schaffner W et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316:363-369.
13. Thomas RE. Benzodiazepine use and motor vehicle accidents. Systematic review of reported association. Can Fam Physician 1998:44:799-808.
14. Patten SB, Williams JV, Love EJ. Self-reported depressive symptoms following treatment with corticosteroids and sedative hypnotics. Int J Psychiatr Med 1996;26:15-24.
15. Salzman C, Salzman C. Pharmacologic treatment of the anxious elderly patient. In: Salzman C, Lebowitiz, BD, eds. Anxiety in the Elderly: Treatment and Research. New York: Springer, 1991.
16. Morgan K, Dallosso H, Ebrahim S et al. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. Br Med J 1988;296: 601-602.
17. Isacson D, Carsjö K, Bergman U, Blackburn JL. Long-term use of benzodiazepines in a Swedish community: An eight-year follow-up. J Clin Epidemiol 1992;45:429-436.
18. Tamblyn RM, McLeod PJ, Abrahamowicz M et al. Questionable prescribing for elderly patients in Quebec. Can Med Assoc J 1994;150:1801-1809.
19. Mant A, Duncan-Jones P, Saltman D et al. Development of long term use of psychotropic drugs by general practice patients. Br Med J 1988;296:251-254.
20. Neutel CI, Maxwell CJ. The benzodiazepine treadmill - does one prescription lead to more. Pharmacoepidemiol Drug Saf 1996;5:39-42.
21. Simon GE, Von Korff M, Barlow W et al. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 1996;49:1067-1073.
22. van Hulten R, Teeuw KG, Bakker A, Luefkens HGM. Prolonged benzodiazepine use predicted in the first 90 days after start of therapy. Pharmacoepidemiol Drug Saf (abstract) 1997;6:S99.
23. Mellinger GD, Balter MB, Uhlenhuth EH. Anti-anxiety agents: Duration of use and characteristics of users in the U.S.A. Curr Med Res Opin 1984; 8(suppl4):21-35.
24. Graham JE, Rockwood K, Beattie BL et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-1796.
25. Nakanishi N, Tatara K, Shinsho F et al. Prevalence of intellectual dysfunctioning and its correlates in a community-residing elderly population. Scand J Soc Med 1998;26:198-203.
26. Hennekens CH, Burings JE. Epidemiology in Medicine. Boston, MA: Little, Brown, 1987.
27. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: Study methods and prevalence of dementia. Can Med Assoc J 1994:150:899-912.
28. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
29. Régie de l'assurance-maladie du Québec. Statistiques annuelles. Québec: Régie de l'assurance-maladie du Québec, 1996.
30. Statistics Canada. The nation: Age, sex and marital status. Ottawa: Statistics Canada, 1992. Catalog no. 93-310-XPB.
31. Moride Y, Abenhaim L. Evidence of the depletion of susceptibles effect in nonexperimental pharmacoepidemiologic research. J Clin Epidemiol 1994; 47:731-737.
32. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197-203.
33. Johnson RE, Hornbrook MC, Nichols GA. Replicating the Chronic Disease Score (CDS) from automated pharmacy data. J Clin Epidemiol 1994;47:1191-1199.
34. SAS Personal Computers. Release 6.03. Cary, NC: SAS Institute, 1987.
35. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc 1991;39:1079-1084.
36. Moride Y. Exposure characterization and risk assessment in pharmacoepidemiology: Non-steroidal anti-inflammatory drugs and gastro-intestinal bleeding. Dissertation. Montreal, QU: McGill University, 1992.
37. National Population Health Survey 1994-95. Public use computer data file. Ottawa, ON: Statistics Canada, 1995.
38. Teboul E, Chouinard G. A guide to benzodiazepine selection. Part II: Clinical aspects. Can J Psychiatry 1991;36:62-73.
39. Devanand DP. Behavioral complications and their treatment in Alzheimer's disease. Geriatrics 1997;52(suppl 2): S37-39.